Fidelity Select Portfolios - Medical Technology and Devices Portfolio

Frequently Asked Questions About FSMEX

What does FSMEX invest in?

This fund typically commits a minimum of 80% of its capital to the securities of companies predominantly involved in the medical technology industry. This includes firms engaged in the research, development, manufacturing, distribution, or sale of medical equipment and related technologies, as well as those supporting drug discovery, and companies providing information technology services primarily to healthcare providers. Its holdings largely consist of common stocks, and it invests in both domestic and international issuers. This is designated as a non-diversified fund.

What is the expense ratio of FSMEX?

Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) charges an expense ratio of 0.62%. This is the annual fee deducted from fund assets to cover management and operations.

How big is FSMEX?

Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) manages $3.56B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation.

Is FSMEX actively managed or an index fund?

FSMEX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was FSMEX launched?

Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) launched in April 1998 and is managed by Fidelity.

How has FSMEX performed?

FSMEX's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.